Live symbol workspace

LLY market intelligence

Chart, AI analysis, key levels, technical analysis, sentiment, and market news are grouped so the next action is always visible.

Current $935.58

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$888.80

Resistance

$982.36

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Analysis

HOLD

Entry $935.58

Stop $888.80

Target $982.36

RSI: 50 | Current: $935.58

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 7 calls in the last 7 days

What sources say

Bullish 1 article

Wolfe Research Says Market Reaction on Eli Lilly (LLY) Foundayo Report Appears Overdone

Insider Trading

Insider	Role	Date	Type	Value
LILLY ENDOWMENT, INC.	Shareholder	May 22 '26	Proposed Sale	312495000.0
LILLY ENDOWMENT, INC.	Shareholder	May 20 '26	Proposed Sale	311530050.0
LILLY ENDOWMENT INC	Former 10% …	May 06 '26	Sale	15754537.0
LILLY ENDOWMENT, INC.	Shareholder	May 06 '26	Proposed Sale	296661000.0
Zakrowski Donald A	SVP, Finance, …	Feb 16 '26	Option Exercise	0.0
Montarce Lucas	EVP & …	Feb 16 '26	Option Exercise	0.0
Custer Kenneth L.	EVP & …	Feb 16 '26	Option Exercise	0.0
Brown Adrienne S	EVP, President …	Feb 16 '26	Option Exercise	0.0
Yuffa Ilya	EVP&Pres, LLY …	Feb 01 '26	Option Exercise	0.0
Skovronsky Daniel	EVP, CS&PO …	Feb 01 '26	Option Exercise	0.0

Source: FinViz — Data may be delayed

Technical Signals

Refreshing technical signals from FinViz…

LLY News Intelligence (13 articles)

AI-curated news influencing LLY price, sentiment, and trend

Explore All LLY News with AI Analysis

Economy

2 months, 1 week ago

Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts

Eli Lilly & Co. shares dip after HSBC turned bearish on the stock, for the second time in a year, …

Impact on LLY: The bearish call from HSBC may lead to a short-term decline in …

Eli Lilly & Co. shares experience a decline after HSBC turns bearish on the stock, … High (70%)

View full analysis →

Bloomberg 70% confidence

Economy

2 months, 2 weeks ago

Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

Impact on LLY: Market impact analysis based on bearish sentiment with 80% confidence.

Eli Lilly's stock is considered overpriced, despite a decline this year, making it a potentially … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

3 months ago

Is Eli Lilly Stock Underperforming the S&P 500?

Eli Lilly has recently trailed the S&P 500 Index, though analysts remain confident in its longer-term trajectory.

Impact on LLY: Market impact analysis based on neutral sentiment with 70% confidence.

Eli Lilly stock has underperformed the S&P 500 Index, but analysts remain optimistic about its … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 months, 2 weeks ago

Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.

Eli Lilly shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 …

Impact on LLY: Market impact analysis based on bullish sentiment with 90% confidence.

Eli Lilly's stock rose after the company announced a $2.4 billion acquisition of Orna Therapeutics, … High (90%)

View full analysis →

Yahoo Finance 90% confidence

Economy

3 months, 3 weeks ago

Earnings live: Supermicro, Eli Lilly stocks pop on upbeat forecasts, AMD and Uber slide

More Big Tech earnings are ahead from Amazon and Alphabet.

Impact on LLY: Market impact analysis based on neutral sentiment with 70% confidence.

Stocks in Supermicro and Eli Lilly have seen an increase due to positive earnings forecasts, … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 months, 3 weeks ago

Eli Lilly Stock Jumps on Strong Earnings. Weight-Loss Drugs Have Something to Do With It.

Eli Lilly reports fourth-quarter earnings and revenue that handily top expectations and issues solid guidance.

Impact on LLY: Market impact analysis based on bullish sentiment with 90% confidence.

Eli Lilly's stock surged due to strong fourth-quarter earnings and revenue that exceeded expectations, with … High (90%)

View full analysis →

Yahoo Finance 90% confidence